Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced Soft Tissue Sarcoma”

159 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 159 results

Testing effectiveness (Phase 2)UnknownNCT03880695
What this trial is testing

Anlotinib Hydrochloride Combined With Liposomal Doxorubicin in the Treatment of Locally Advanced or Metastatic Soft Tissue Sarcoma

Who this might be right for
Sarcoma
Peking University People's Hospital 48
Testing effectiveness (Phase 2)UnknownNCT03816475
What this trial is testing

Hypofractionated Radiotherapy in Locally Advanced Myxoid Liposarcomas of Extremities or Trunk Wall (LIPO-MYX Trial)

Who this might be right for
Myxoid Liposarcoma
Maria Sklodowska-Curie National Research Institute of Oncology 35
Early research (Phase 1)Study completedNCT01325558
What this trial is testing

ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Locally Advanced Malignant NeoplasmMalignant Solid Tumour
Altor BioScience 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT01267955
What this trial is testing

Vismodegib in Treating Patients With Advanced Chondrosarcomas

Who this might be right for
Clear Cell ChondrosarcomaDedifferentiated ChondrosarcomaLocally Advanced Chondrosarcoma+4 more
National Cancer Institute (NCI) 45
Testing effectiveness (Phase 2)Study completedNCT01327612
What this trial is testing

Open Label Extension Study of Conatumumab and Ganitumab (AMG 479)

Who this might be right for
Advanced Solid TumorsCarcinoidColorectal Cancer+6 more
Amgen 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT03778996
What this trial is testing

SM-88 Maintenance Therapy for Advanced Ewing's Sarcoma and as Salvage Therapy for Sarcoma

Who this might be right for
Sarcoma, EwingSarcoma
Sarcoma Oncology Research Center, LLC 31
Testing effectiveness (Phase 2)Study completedNCT00005066
What this trial is testing

O6-benzylguanine and Carmustine in Treating Patients With Recurrent, Metastatic, or Locally Advanced Soft Tissue Sarcoma

Who this might be right for
Sarcoma
University of Chicago 12
Testing effectiveness (Phase 2)Study completedNCT02453191
What this trial is testing

TVEC and Preop Radiation for Sarcoma (4 ml Dose)

Who this might be right for
Soft Tissue Sarcoma
University of Iowa 30
Early research (Phase 1)Study completedNCT03009201
What this trial is testing

Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery

Who this might be right for
Advanced Soft Tissue SarcomaLocally Advanced AngiosarcomaLocally Advanced Leiomyosarcoma+24 more
OHSU Knight Cancer Institute 16
Large-scale testing (Phase 3)Study completedNCT01440088
What this trial is testing

A Trial of TH-302 in Combination With Doxorubicin Versus Doxorubicin Alone to Treat Patients With Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma
Threshold Pharmaceuticals 640
Testing effectiveness (Phase 2)UnknownNCT05189483
What this trial is testing

Albumin-bound Paclitaxel Plus Camrelizumab for Advanced Soft Tissue Sarcoma.

Who this might be right for
Soft Tissue Sarcoma
Henan Cancer Hospital 40
Testing effectiveness (Phase 2)Study completedNCT00005862
What this trial is testing

SU5416 in Treating Patients With Advanced, Metastatic, or Recurrent Soft Tissue Sarcomas

Who this might be right for
Gastrointestinal Stromal TumorSarcoma
National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Study completedNCT00085475
What this trial is testing

Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans or Giant Cell Fibroblastoma

Who this might be right for
Sarcoma
European Organisation for Research and Treatment of Cancer - EORTC 17
Testing effectiveness (Phase 2)Study completedNCT02066675
What this trial is testing

Trabectedin First Line Therapy In Unfit Sarcoma Study

Who this might be right for
Metastatic and Locally Advanced Soft Tissue Tumor Patients Unfit to ReceiveStandard Chemotherapy
Italian Sarcoma Group 24
Early research (Phase 1)Looking for participantsNCT06440005
What this trial is testing

Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

Who this might be right for
CancerAdvanced CancerLocally Advanced Carcinoma+8 more
Angiex, Inc. 80
Early research (Phase 1)Ended earlyNCT02387125
What this trial is testing

Phase 1b Safety Study of CMB305 in Patients With Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1

Who this might be right for
SarcomaMelanomaNon-small Cell Lung Cancer+1 more
Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 79
Testing effectiveness (Phase 2)Active Not RecruitingNCT03414229
What this trial is testing

Epacadostat, an IDO1 Inhibitor, in Combination With Pembrolizumab in Patients With Metastatic and/or Locally Advanced Sarcoma

Who this might be right for
Sarcoma
Memorial Sloan Kettering Cancer Center 30
Early research (Phase 1)Active Not RecruitingNCT05827614
What this trial is testing

Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene Amplifications

Who this might be right for
Triple Negative Breast Cancer (TNBC)High Grade Serous Ovarian CarcinomaHigh Grade Endometrial Carcinoma+9 more
Boundless Bio 85
Large-scale testing (Phase 3)Active Not RecruitingNCT01933932
What this trial is testing

Assess Efficacy & Safety of Selumetinib in Combination With Docetaxel in Patients Receiving 2nd Line Treatment for v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Positive NSCLC

Who this might be right for
Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV
AstraZeneca 510
Early research (Phase 1)Study completedNCT02573259
What this trial is testing

A Dose Escalation Study Of PF-06801591 In Melanoma, Head And Neck Cancer (SCCHN), Ovarian, Sarcoma, Non-Small Cell Lung Cancer, Urothelial Carcinoma or Other Solid Tumors

Who this might be right for
Part 1MELANOMASCCHN+6 more
Pfizer 147
Load More Results